• The Journal of Internal Korean Medicine
• /
• v.38 no.5
• /
• pp.834-841
• /
• 2017

Objectives: To report the clinical application and effects of ByeolGab (Trionycis Carapax) pharmacopuncture in patients with primary headache. Method: Three patients who suffered from primary headache were treated with ByeolGab pharmacopuncture and acupuncture for 2 weeks. We used the Henry Ford Headache Disability Inventory (HDI), a six point scale, and a visual analogue scale (VAS) three times and analyzed the results. Result: After treatment with ByeolGab pharmacopuncture, the VAS, HDI, and six point scale scores were improved in all three patients. The symptoms of headache and other symptoms were also improved. Conclusion: ByeolGab pharmacopuncture is an effective treatment for patients complaining of primary headache.

• The Journal of Internal Korean Medicine
• /
• v.39 no.5
• /
• pp.870-878
• /
• 2018

Objectives: The aim of this study is to report the effects of Korean medical treatment with ByeolGab pharmacopuncture on a patient with a tension-type headache. Methods: We treated a tension-type headache using Korean medical treatment including ByeolGab pharmacopuncture for 6 days a week for 2 weeks. As a measurement, the numerical rating scale (NRS), the Henry Ford Headache Disability Inventory (HDI), and a six point Likert scale were used to confirm pharmacopuncture therapy efficacy. Results: After treatment, symptoms related to tension-type headache and other complaints were decreased and evaluation using the NRS, HDI, and six-point scale showed improvement in the patient. Conclusions: This study shows that Korean medical treatment with ByeolGab pharmacopuncture has beneficial effects on control of tension-type headache and improvement in quality of life for patients.